Healthy adults
Conditions
Interventions
4 weeks consumption of control food >
wash out (4 weeks) >
4 weeks consumption of test food
4 weeks consumption of test food >
4 weeks consumption of control food
Sponsors
Kao Corporation
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1) Adult aged from 20 y to 60 y (2) Fasting glucose from 70 to 125 mg/dL
Exclusion criteria
Exclusion criteria: (1) Diabetes mellitus (2) Taking medicine related diabetes mellitus (3) BMI>=30kg/m2 (4) Blood triglyceride>=150mg/dL (5) Taking antihypertensive (6) Having history or presence of cardiovascular disease or cerebrovascular disease (7) Presence of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (8) Having history of resection of gastrointestinal tract (9) Thyroid deficiency (10) Heavy alcohol drinker (over 30g per day) (11) Donated over 200 mL of blood within the last one month prior to the study or over 400 mL of blood within the last three months prior to the study or severe anemia (12) Having felt sick during blood collection (13) Food allergies for test foods or lactose intolerance (14) Tape allergy (15) Caffeine hypersensitivity (16) Planned to participate in other clinical study during current study (17) Shift worker (18) Planned to be examined by X-ray, CT, or MRI (19) Using an implantable medical device such as a pacemaker (20) Undergoing artificial dialysis (21) Within the last 2 weeks, having flu symptoms such as fever, cough, or sore throat, high fever, dyspnea, strong malaise, taste disorders, or olfactory disorders (22) Within the last 2 weeks, having family members or friends infected with COVID-19 or having close contact with infected person (23) Having overseas travel history within 1 month (24) Determined to be unqualified by the physician in charge or the responsible person of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concentration of blood glucose | — |
Secondary
| Measure | Time frame |
|---|---|
| Concentration of blood insulin, GLP-1, and GIP | — |
Countries
Japan
Contacts
Public ContactAya Yanagimoto
Kao Corporation Biological Science Research laboratories
Outcome results
None listed